Course content

A list of the course contents is given on the website, link below. It includes a visit to a small-scale biomanufacturing facility.

Learning Outcomes 

A. To gain an understanding of the vaccine development process, including GMP manufacture and testing vaccine safety and efficacy in clinical trials.

B.To be able to apply the understanding to vaccines being designed, manufactured and developed by the participant

Course Goals 

  1. To give an overview of vaccine biomanufacturing including considerations for taking pre-clinical vaccine candidates into GMP manufacture, the principles of GMP (good manufacturing practice), and an overview of small to large scale manufacture.

  2. To provide an overview of vaccine clinical development including examples from experimental and licensed vaccines; to impart the importance of clinical trial design, immunomonitoring, statistical considerations and ethical considerations.

Timeline 

Application Deadline:  

1 July 2020

Course Dates:

Q4 2020 (4 days)

Contact 

Wendy Crocker wendy.crocker@ndm.ox.ac.uk

M1  Clinical vaccine development and biomanufacturing